Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析

◆英語タイトル:Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1345
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:88
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Johnson & Johnson (JNJ) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Johnson & Johnson (J&J) researches, develops, manufactures and sells pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopaedic, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson Key Recent Developments

Apr 01,2020: Johnson & Johnson postpones 2020 medical devices business review due to the Coronavirus
Mar 31,2020: US HHS expedites development and manufacture of Covid-19 vaccines
Mar 31,2020: Johnson & Johnson targets Phase I study in September after selecting lead COVID-19 vaccine candidate
Mar 31,2020: Johnson & Johnson secures $456m for coronavirus therapy
Mar 30,2020: J&J partners with BARDA to commit $1bn to Covid-19 vaccine development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Johnson & Johnson – Key Facts
Johnson & Johnson – Key Employees
Johnson & Johnson – Key Employee Biographies
Johnson & Johnson – Major Products and Services
Johnson & Johnson – History
Johnson & Johnson – Company Statement
Johnson & Johnson – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Johnson & Johnson – Business Description
Business Segment: Consumer
Overview
Performance
Key Stats
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific, Africa
Performance
Geographical Segment: Europe
Performance
Geographical Segment: United States
Performance
Geographical Segment: Western Hemisphere excluding U.S.
Performance
R&D Overview
Johnson & Johnson – Corporate Strategy
Johnson & Johnson – SWOT Analysis
SWOT Analysis – Overview
Johnson & Johnson – Strengths
Johnson & Johnson – Weaknesses
Johnson & Johnson – Opportunities
Johnson & Johnson – Threats
Johnson & Johnson – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Johnson & Johnson, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2020: US HHS expedites development and manufacture of Covid-19 vaccines
Mar 30, 2020: J&J partners with BARDA to commit $1bn to Covid-19 vaccine development
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
Mar 17, 2020: J&J says no evidence darunavir works against coronavirus
Mar 16, 2020: J&J’s Janssen and BIDMC team up on Covid-19 vaccine
Mar 10, 2020: Johnson & Johnson’s CAR-T partner Legend Biotech plans IPO
Feb 28, 2020: GSK and partners launch TB treatments collaboration
Feb 27, 2020: First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
Feb 19, 2020: J&J and HHS expand alliance to identify coronavirus drugs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Johnson & Johnson, Key Facts
Johnson & Johnson, Key Employees
Johnson & Johnson, Key Employee Biographies
Johnson & Johnson, Major Products and Services
Johnson & Johnson, History
Johnson & Johnson, Subsidiaries
Johnson & Johnson, Key Competitors
Johnson & Johnson, Ratios based on current share price
Johnson & Johnson, Annual Ratios
Johnson & Johnson, Annual Ratios (Cont...1)
Johnson & Johnson, Annual Ratios (Cont...2)
Johnson & Johnson, Interim Ratios
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Johnson & Johnson, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Johnson & Johnson, Performance Chart (2015 - 2019)
Johnson & Johnson, Ratio Charts
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shire Plc (SHP)-製薬・医療分野:企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Newalta Corp (NAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Newalta Corp (Newalta) is a provider of sustainability-enhancing solutions to the oil and gas industry. It adopts technologies to maximize the value inherent in oil and gas exploration and production waste streams. The company provides engineered environmental solutions for waste management …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • Australian Agricultural Company Limited:企業の戦略・SWOT・財務分析
    Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Agricultural Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Hermes International SA:企業の戦略・SWOT・財務分析
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Grupo SATA:企業の戦略的SWOT分析
    Grupo SATA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sino Gas & Energy Holdings Ltd (SEH):企業の財務・戦略的SWOT分析
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • Wilmar International Limited:企業の戦略・SWOT・財務分析
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Pharmagest Interactive SA (PHA):企業の財務・戦略的SWOT分析
    Summary Pharmagest Interactive SA (Pharmagest Interactive) is a technology company that develops and markets professional IT solutions for pharmacies and pharmaceutical industries. The company operates through four divisions such as pharmaceutical, fintech, e-health, and health and medico-social div …
  • REC Silicon ASA (REC):電力:M&Aディール及び事業提携情報
    Summary REC Silicon ASA (REC Silicon), formerly Renewable Energy Corporation ASA, is a producer of advanced silicon materials, and delivers high-purity polysilicon and silicon gas. Its products find application in the solar and electronics industries in the production of solar panels, flat panel dis …
  • East Japan Railway Co:戦略・SWOT・企業財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sage Therapeutics Inc (SAGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The company ha …
  • Atlantic Power Corporation:発電所・企業SWOT分析
    Atlantic Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Wartsila Corporation (WRT1V)-エネルギー分野:企業M&A・提携分析
    Summary Wartsila Corporation (Wartsila) offers a complete lifecycle power solutions and advanced technologies for the marine and energy markets. It provides low- and medium-speed engines, seals and bearings, automation systems, pumps and valves, ship design and ballast water treatment systems to shi …
  • Sangoma Technologies Corporation (STC):企業の財務・戦略的SWOT分析
    Sangoma Technologies Corporation (STC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • SI2 Technologies, Inc.:企業の戦略・SWOT・財務情報
    SI2 Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary SI2 Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • GBST Holdings Limited (GBT):企業の財務・戦略的SWOT分析
    GBST Holdings Limited (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆